Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
AKBA compared with FLGT: revenue, margins and what each company keeps, and the suppliers and customers both name
AKBA
Akebia Therapeutics, Inc.
Change
Mkt cap
Revenue
Revenue
FLGT
Fulgent Genetics, Inc.
Change
Mkt cap
Revenue
Revenue
vs
Compare
AKBA
Akebia Therapeutics, Inc.
vs
FLGT
Fulgent Genetics, Inc.
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Price
Desk
News
Calendar
Saved
Search
Price
rebased to 0%
1D
1W
1M
3M
YTD
1Y
5Y
1D
1W
1M
3M
YTD
1Y
5Y
AKBA, solid
FLGT, dashed
AKBA
Akebia Therapeutics, Inc.
Change
0.74
▲
+0.20%
· post 0.71
Mkt cap
$195.8M
Revenue
$49M
Q2 FY26
Revenue
$236M
FY25
FLGT
Fulgent Genetics, Inc.
Change
20.59
▼
−5.04%
· post 20.59
Closed
Oct 30 '26
Mkt cap
$567.4M
Revenue
$85M
Q2 FY26
Revenue
$323M
FY25
vs
Compare
Closed
Oct 30 '26
AKBA
Akebia Therapeutics, Inc.
vs
FLGT
Fulgent Genetics, Inc.
0.74
▲
+0.20%
post 0.71
Price
20.59
▼
−5.04%
post 20.59
$195.8M
Mkt cap
$567.4M
Q2 FY26
$49M
Revenue
$85M
Q2 FY26
FY25
$236M
Revenue
$323M
FY25
Change
Change
AKBA
0.74
▲
+0.20%
vs
FLGT
20.59
▼
−5.04%
Closed
Oct 30 '26